Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Stapled peptide inhibitors of NEMO as potential anti-inflammatory and anti-cancer drugs

Stapled peptide inhibitors of NEMO as potential anti-inflammatory and anti-cancer drugs

US Patent 11149070 · Granted Oct 19, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Stapled peptide inhibitors of nemo as potential anti-inflammatory and anti-cance2024
Stapled peptide inhibitors of nemo as potential anti-inflammatory and anti-cance2024
Stapled peptide inhibitors of nemo as potential anti-inflammatory and anti-cance2024
Stapled peptide inhibitors of nemo as potential anti-inflammatory and anti-cance2024
Peptidomimetics, method of synthesis and uses thereof2022
Peptidomimetics, method of synthesis and uses thereof2022
Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their n2018
Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their n2018
Conjugated molecules comprising a peptide derived from the CD4 receptor coupled 2018
Conjugated molecules comprising a peptide derived from the CD4 receptor coupled 2018
Glycoconjugates and their use as potential vaccines against infection by Shigell2016
Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their n2016